Renoprotective action of L-carnitine in fructose-induced metabolic syndrome

被引:23
作者
Rajasekar, P. [1 ]
Viswanathan, P. [2 ]
Anuradha, C. V. [1 ]
机构
[1] Annamalai Univ, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India
[2] Annamalai Univ, Rajah Muthiah Med Coll, Dept Pathol, Annamalainagar 608002, Tamil Nadu, India
关键词
fructose diet; immunostaining; insulin resistance; lipotoxicity; oxidative stress; renal damage;
D O I
10.1111/j.1463-1326.2007.00825.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Rats fed high dosage of fructose that form a well-known experimental model of the metabolic syndrome also display progressive renal disturbances. The present study evaluates the influence of L-carnitine (CA) administration on oxidant-antioxidant balance, protein damage and lipid levels in kidney of rats administered high dose of fructose. Methods: Adult male Wistar rats were divided into four groups of 10 rats each. Groups I and IV animals received starch-based control diet, while groups II and III rats were fed a high-fructose diet (60 g/100 g). Groups III and IV animals additionally received CA (300 mg/kg/day) for 60 days. The extent of lipid peroxidation, enzymatic and non-enzymatic antioxidants and lipid levels were measured after 60 days. The accumulation of nitrated and oxidatively modified proteins in kidney was also measured by immunohistochemical study with specific antibodies. Results: Fructose-fed rats exhibited increased levels of peroxidation end products, diminished antioxidant status, increased staining for the presence of 4-hydroxy-2-nonenal, 2,4-dinitrophenol and 3-nitrotyrosine protein adducts and lipid accumulation in kidney. CA administration attenuated these pathological renal alterations. Conclusions: The benefits of CA in this model suggest the therapeutic use of CA to counter the kidney changes associated with metabolic syndrome.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 44 条
  • [1] Cytosolic triglycerides and oxidative stress in central obesity:: the missing link between excessive atherosclerosis, endothelial dysfunction, and β-cell failure?
    Bakker, SJL
    IJzerman, RG
    Teerlink, T
    Westerhoff, HV
    Gans, ROB
    Heine, RJ
    [J]. ATHEROSCLEROSIS, 2000, 148 (01) : 17 - 21
  • [2] Balakrishnan SD, 1999, MED SCI RES, V27, P489
  • [3] GLYCATION PRODUCTS AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS
    BROWNLEE, M
    [J]. DIABETES CARE, 1992, 15 (12) : 1835 - 1843
  • [4] Cytochrome c:: a catalyst and target of nitrite-hydrogen peroxide-dependent protein nitration
    Castro, L
    Eiserich, JP
    Sweeney, S
    Radi, R
    Freeman, BA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 421 (01) : 99 - 107
  • [5] High-fructose diet decreases catalase mRNA levels in rat tissues
    Cavarape, A
    Feletto, F
    Mercuri, F
    Quagliaro, L
    Damante, G
    Ceriello, A
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (11) : 838 - 845
  • [6] VITAMIN-E REDUCTION OF PROTEIN GLYCOSYLATION IN DIABETES - NEW PROSPECT FOR PREVENTION OF DIABETIC COMPLICATIONS
    CERIELLO, A
    GIUGLIANO, D
    QUATRARO, A
    DONZELLA, C
    DIPALO, G
    LEFEBVRE, PJ
    [J]. DIABETES CARE, 1991, 14 (01) : 68 - 72
  • [7] L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine
    Chang, BJ
    Nishikawa, M
    Sato, E
    Utsumi, K
    Inoue, M
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 405 (01) : 55 - 64
  • [8] 4-hydroxynonenal inhibits interleukin-1 beta converting enzyme
    Davis, DW
    Hamilton, RF
    Holian, A
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (04) : 205 - 210
  • [9] Del Corso A, 1998, ARCH BIOCHEM BIOPHYS, V350, P245
  • [10] DILLARD CJ, 1974, METHOD ENZYMOL, V105, P337